×
MOTS-C 10mg Research Peptide NAD+ 500mg Research Compound
First Order Offer
RMJS 1,000+ researchers subscribed

Get 10% Off
Your First Order

Purity-verified research compounds with third-party COAs. Fast shipping from Colorado.

Order before 12 PM MST — ships same day
99%+ Purity Secure Checkout COA Verified
No thanks, I'll pay full price No spam. Unsubscribe anytime. For research use only.

You're In!

Check your email for your exclusive 10% discount code.

Shop Now
🚚 FREE SHIPPING on all orders over $150⏱ Order before 12 PM MT — ships the same day🧪 99%+ purity — third-party COA with every batch💳 Pay by Card, Venmo, Zelle, ACH or Cash App🎁 FREE bacteriostatic water with every order📱 Customer care — Text us: (720) 285-5706🌐 Shipped from Denver, Colorado🚚 FREE SHIPPING on all orders over $150⏱ Order before 12 PM MT — ships the same day🧪 99%+ purity — third-party COA with every batch💳 Pay by Card, Venmo, Zelle, ACH or Cash App🎁 FREE bacteriostatic water with every order📱 Customer care — Text us: (720) 285-5706🌐 Shipped from Denver, Colorado🚚 FREE SHIPPING on all orders over $150⏱ Order before 12 PM MT — ships the same day🧪 99%+ purity — third-party COA with every batch💳 Pay by Card, Venmo, Zelle, ACH or Cash App🎁 FREE bacteriostatic water with every order📱 Customer care — Text us: (720) 285-5706🌐 Shipped from Denver, Colorado🚚 FREE SHIPPING on all orders over $150⏱ Order before 12 PM MT — ships the same day🧪 99%+ purity — third-party COA with every batch💳 Pay by Card, Venmo, Zelle, ACH or Cash App🎁 FREE bacteriostatic water with every order📱 Customer care — Text us: (720) 285-5706🌐 Shipped from Denver, Colorado
Free VectorFam Slider Case with 10 or more research vials — automatically added at checkout.

Survodutide: The Glucagon/GLP-1 Dual Agonist Advancing 2026 Hepatic Research

Introduction to Survodutide Research Survodutide represents a novel class of therapeutic peptides currently dominating 2026 metabolic and hepatic research. Co-invented by Boehringer Ingelheim and Zealand Pharma, survodutide is a dual agonist that targets both the glucagon receptor (GCGR) and the glucagon-like peptide-1 receptor (GLP-1R). This dual mechanism differentiates it from selective GLP-1 agonists and has […]

Vector Team